Bank stocks led European equities traded in the US as American depositary receipts higher late Tuesday morning, rising 0.80% to 1,418.65 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Ericsson (ERIC) and biopharmaceutical company Grifols (GRFS), which rose 3.3% and 2.7% respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which increased 2.6% and 2.2% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and 3D printer company Materialise (MTLS), which shed 10% and 8% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies (DBVT), which dropped 4.3% and 1.2% respectively.
From the UK and Ireland, the gainers were led by medical device maker Smith & Nephew (SNN) and financial services company HSBC (HSBC), which were up 6.1% and 2.6% respectively. They were followed by pharmaceutical company GSK (GSK) and financial services company Lloyds Banking Group (LYG), which advanced 2.6% and 1.5% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which fell 7% and 5.3% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which were down 7.8% and 3%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。